B. Dubois, H. Feldman, and C. Jacova, Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS???ADRDA criteria, The Lancet Neurology, vol.6, issue.8, pp.734-780, 2007.
DOI : 10.1016/S1474-4422(07)70178-3

B. Dubois, H. Feldman, and C. Jacova, Revising the definition of Alzheimer's disease: a new lexicon, The Lancet Neurology, vol.9, issue.11, pp.1118-1145, 2010.
DOI : 10.1016/S1474-4422(10)70223-4

R. Sperling, P. Aisen, and L. Beckett, Toward defining the preclinical stages of Alzheimer???s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimer's & Dementia, vol.7, issue.3, pp.280-92, 2011.
DOI : 10.1016/j.jalz.2011.03.003

M. Albert, S. Dekosky, and D. Dickson, The diagnosis of mild cognitive impairment due to Alzheimer???s disease: Recommendations from the National Institute on Aging-Alzheimer???s Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimer's & Dementia, vol.7, issue.3, pp.270-279, 2011.
DOI : 10.1016/j.jalz.2011.03.008

G. Mckhann, D. Knopman, and H. Chertkow, The diagnosis of dementia due to Alzheimer???s disease: Recommendations from the National Institute on Aging-Alzheimer???s Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimer's & Dementia, vol.7, issue.3, pp.263-272, 2011.
DOI : 10.1016/j.jalz.2011.03.005

B. Dubois, H. Hampel, and H. Feldman, Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria, Alzheimer's & Dementia, vol.12, issue.3, pp.292-323, 2016.
DOI : 10.1016/j.jalz.2016.02.002

L. Clark, A. Racine, and R. Koscik, Beta-amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer's Prevention study, Alzheimer's & Dementia, vol.12, issue.7, pp.805-814, 2016.
DOI : 10.1016/j.jalz.2015.12.009

M. C. Donohue, R. A. Sperling, D. P. Salmon, D. M. Rentz, R. Raman et al., The Preclinical Alzheimer Cognitive Composite, JAMA Neurology, vol.71, issue.8, pp.961-970, 2014.
DOI : 10.1001/jamaneurol.2014.803
URL : http://archneur.jamanetwork.com/data/journals/neur/930612/noi140029.pdf

J. B. Langbaum, S. B. Hendrix, N. Ayutyanont, K. Chen, A. S. Fleisher et al., An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease, Alzheimer's & Dementia, vol.10, issue.6, pp.666-674, 2014.
DOI : 10.1016/j.jalz.2014.02.002

Y. Y. Lim, P. Maruff, R. H. Pietrzak, D. Ames, K. A. Ellis et al., Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer???s disease, Brain, vol.51, issue.1, pp.221-231, 2014.
DOI : 10.2967/jnumed.109.069088

Y. Y. Lim, P. J. Snyder, R. H. Pietrzak, A. Ukiqi, V. L. Villemagne et al., Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score, Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, vol.2, pp.19-26, 2016.
DOI : 10.1016/j.dadm.2015.11.003

E. Mormino, K. Papp, D. Rentz, M. Donohue, R. Amariglio et al., Sperling. RA Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid-?. Alzheimers Dement, p.28253478

M. Folstein, S. Folstein, and P. Mchugh, ???Mini-mental state???, Journal of Psychiatric Research, vol.12, issue.3, pp.189-198, 1975.
DOI : 10.1016/0022-3956(75)90026-6

J. Morris, The Clinical Dementia Rating (CDR): Current version and scoring rules, Neurology, vol.43, issue.11, pp.2412-2414, 1993.
DOI : 10.1212/WNL.43.11.2412-a

E. Grober, H. Buschke, H. Crystal, S. Bang, and R. Dresner, Screening for dementia by memory testing, Neurology, vol.38, issue.6, pp.900-903, 1988.
DOI : 10.1212/WNL.38.6.900

M. Mcnair and R. Kahn, Self-assessment of cognitive deficits Assessment in geriatric psychopharmacology, pp.137-144, 1983.

P. Monahan, M. Boustani, and C. Alder, Practical clinical tool to monitor dementia symptoms: the HABC-Monitor, Clinical Interventions in Aging, vol.7, pp.143-57, 2012.
DOI : 10.2147/CIA.S30663

J. Cummings, M. Mega, K. Gray, S. Rosenberg-thompson, D. Carusi et al., The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia, Neurology, vol.44, issue.12, pp.2308-2322, 1994.
DOI : 10.1212/WNL.44.12.2308

C. Spielberger, R. Gorsuch, R. Lushene, P. Vagg, and G. Jacobs, Manual for the State-Trait Anxiety Inventory, 1983.

J. Yesavage, T. Brink, and T. Rose, Development and validation of a geriatric depression screening scale: A preliminary report, Journal of Psychiatric Research, vol.17, issue.1, pp.37-49, 1982.
DOI : 10.1016/0022-3956(82)90033-4

S. Starkstein, R. Migliorelli, and F. Manes, The prevalence and clinical correlates of apathy and irritability in Alzheimer's disease, European Journal of Neurology, vol.9, issue.suppl. 236, pp.540-546, 1995.
DOI : 10.1080/03610738308258434

R. Bucks, D. Ashworth, G. Wilcock, and K. Siegfried, Assessment of Activities of Daily Living in Dementia: Development of the Bristol Activities of Daily Living Scale, Age and Ageing, vol.25, issue.2, pp.113-133, 1996.
DOI : 10.1093/ageing/25.2.113

R. Brooks, EuroQol: the current state of play, Health Policy, vol.37, issue.1, pp.53-72, 1996.
DOI : 10.1016/0168-8510(96)00822-6

E. Barbeau, M. Didic, and E. Tramoni, Evaluation of visual recognition memory in MCI patients, Neurology, vol.62, issue.8, pp.1317-1322, 2004.
DOI : 10.1212/01.WNL.0000120548.24298.DB

P. Osterrieth, Le test de copie d'une figure complexe: Contribution à l'étude de la perception et de la mémoire, Archives de Psychologie, vol.30, pp.286-35619, 1944.

H. Buschke and W. Mowrey, Ramratan WS et al Memory Binding Test Distinguishes Amnestic Mild Cognitive Impairment and Dementia from Cognitively Normal Elderly, Arch Clin Neuropsychol. Feb, vol.32, issue.1, pp.29-39, 2017.
DOI : 10.1093/arclin/acw083

B. Dubois, A. Slachevsky, I. Litvan, and B. Pillon, The FAB: A frontal assessment battery at bedside, Neurology, vol.55, issue.11, pp.1621-1626, 2000.
DOI : 10.1212/WNL.55.11.1621

T. Tombaugh, Trail Making Test A and B: Normative data stratified by age and education, Archives of Clinical Neuropsychology, vol.19, issue.2, pp.203-214, 2004.
DOI : 10.1016/S0887-6177(03)00039-8
URL : https://academic.oup.com/acn/article-pdf/19/2/203/8769/19-2-203.pdf

L. Thurstone, L. L. By, and . Thurstone, Psychophysical Analysis, The American Journal of Psychology, vol.100, issue.3/4, pp.587-609, 1927.
DOI : 10.2307/1422696

G. Deloche, D. Hannequin, and M. Dordain, Picture Confrontation Oral Naming: Performance Differences between Aphasics and Normals, Brain and Language, vol.53, issue.1, pp.105-120, 1996.
DOI : 10.1006/brln.1996.0039

P. Peigneux and M. Van-der-liden, Presentation d'une batterie neuropsychologique et cognitive pour l'evaluation de l'apraxie gestuelle, pp.311-362, 2000.

C. Clark, J. Schneider, and B. Bedell, Use of Florbetapir-PET for Imaging ??-Amyloid Pathology, JAMA, vol.305, issue.3, pp.275-83, 2011.
DOI : 10.1001/jama.2010.2008

F. Cacciamani, C. Tandetnik, G. Gagliardi, H. Bertin, M. Habert et al., INSIGHT-PreAD study group. Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's Disease, J Alzheimers Dis, vol.59, issue.2, pp.753-762, 2017.

F. Besson, L. Joie, R. Doeuvre, and L. , Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer's Disease, Journal of Neuroscience, vol.35, issue.29, pp.10402-10413, 2015.
DOI : 10.1523/JNEUROSCI.0150-15.2015

L. Joie, R. Perrotin, A. Barré, L. Hommet, C. Mézenge et al., Region-Specific Hierarchy between Atrophy, Hypometabolism, and ??-Amyloid (A??) Load in Alzheimer's Disease Dementia, Journal of Neuroscience, vol.32, issue.46, pp.16265-73, 2012.
DOI : 10.1523/JNEUROSCI.2170-12.2012

S. Landau, B. Thomas, L. Thurfjell, M. Schmidt, R. Margolin et al., Amyloid PET imaging in Alzheimer???s disease: a comparison of three radiotracers, European Journal of Nuclear Medicine and Molecular Imaging, vol.36, issue.10, pp.411398-407, 2014.
DOI : 10.1007/s00259-009-1129-6

C. Jack, . Jr, D. Knopman, and S. Weigand, An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease, Annals of Neurology, vol.290, issue.pt 8, pp.765-75, 2012.
DOI : 10.1001/jama.290.12.1624

M. Chupin, A. Hammers, and R. Liu, Automatic segmentation of the hippocampus and the amygdala driven by hybrid constraints: Method and validation, NeuroImage, vol.46, issue.3, pp.749-61, 2009.
DOI : 10.1016/j.neuroimage.2009.02.013
URL : https://hal.archives-ouvertes.fr/hal-00805390

K. Blennow, H. Hampel, M. Weiner, and H. Zetterberg, Cerebrospinal fluid and plasma biomarkers in Alzheimer disease, Nature Reviews Neurology, vol.359, issue.3, pp.131-175, 2010.
DOI : 10.1016/j.bbadis.2004.09.008

S. Epelbaum, R. Genthon, and E. Cavedo, Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept, Alzheimer's & Dementia, vol.13, issue.4, 2017.
DOI : 10.1016/j.jalz.2016.12.003

B. Dubois, H. Feldman, C. Jacova, H. Hampel, J. Molinuevo et al., Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria, The Lancet Neurology, vol.13, issue.6, pp.614-643, 2014.
DOI : 10.1016/S1474-4422(14)70090-0

D. Simel, G. Samsa, and D. Matchar, Likelihood ratios with confidence: Sample size estimation for diagnostic test studies, Journal of Clinical Epidemiology, vol.44, issue.8, pp.763-70, 1991.
DOI : 10.1016/0895-4356(91)90128-V

C. Rowe, D. Ames, K. Ellis, P. Bourgeat, B. Brown et al., Biomarker-based prediction of cognitive decline in 270 nondemented older individuals: Three-year follow-up results from the Australian Imaging Biomarkers and Lifestyle Study of Aging (AIBL) 2013 Alzheimer Dementia, p.12, 20139-07.

W. Jansen, R. Ossenkoppele, and D. Knol, Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia, JAMA, vol.313, issue.19, pp.1924-1962, 2015.
DOI : 10.1001/jama.2015.4668

C. Duyckaerts, Tau pathology in children and young adults: can you still be unconditionally baptist?, Acta Neuropathologica, vol.2, issue.2, pp.145-152, 2011.
DOI : 10.1038/nm0196-93

V. Villemagne, K. Pike, and G. Chételat, Longitudinal assessment of A?? and cognition in aging and Alzheimer disease, Annals of Neurology, vol.29, issue.1, pp.181-92, 2011.
DOI : 10.1016/j.neurobiolaging.2007.03.029

S. Vos, C. Xiong, and P. Visser, Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study, The Lancet Neurology, vol.12, issue.10, pp.957-65, 2013.
DOI : 10.1016/S1474-4422(13)70194-7

A. Soldan, C. Pettigrew, and Q. Cai, Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change, JAMA Neurology, vol.73, issue.6, pp.698-705, 2016.
DOI : 10.1001/jamaneurol.2016.0194
URL : http://archneur.jamanetwork.com/data/journals/neur/935350/noi160013.pdf

K. Papp, R. Amariglio, E. Mormino, T. Hedden, M. Dekhytar et al., Free and cued memory in relation to biomarker-defined abnormalities in clinically normal older adults and those at risk for Alzheimer???s disease, Neuropsychologia, vol.73, pp.169-75, 2015.
DOI : 10.1016/j.neuropsychologia.2015.04.034

D. Tisserand and J. Jolles, On the involvement of prefrontal networks in cognitive ageing. Cortex, pp.4-51107, 2003.

A. Du, N. Schuff, L. Chao, J. Kornak, W. Jagust et al., Age effects on atrophy rates of entorhinal cortex and hippocampus, Neurobiology of Aging, vol.27, issue.5, pp.733-773, 2005.
DOI : 10.1016/j.neurobiolaging.2005.03.021

R. Buckley, M. Saling, D. Ames, C. Rowe, N. Lautenschlager et al., Factors affecting subjective memory complaints in the AIBL aging study: biomarkers, memory, affect, and age, Australian Imaging Biomarkers and Lifestyle Study of Aging (AIBL) Research Group
DOI : 10.1097/WAD.0b013e3181f81094

S. Hollands, Y. Lim, R. Buckley, R. Pietrzak, P. Snyder et al., Amyloid-? related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults, J Alzheimers Dis, vol.43, issue.2, pp.677-86, 2015.

R. Amariglio, J. Becker, and J. Carmasin, Subjective cognitive complaints and amyloid burden in cognitively normal older individuals, Neuropsychologia, vol.50, issue.12, pp.2880-2886, 2012.
DOI : 10.1016/j.neuropsychologia.2012.08.011

F. Jessen, R. Amariglio, and M. Van-boxtel, A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease, Alzheimer's & Dementia, vol.10, issue.6, pp.844-52, 2014.
DOI : 10.1016/j.jalz.2014.01.001

G. Turner and R. Spreng, Prefrontal Engagement and Reduced Default Network Suppression Co-occur and Are Dynamically Coupled in Older Adults: The Default???Executive Coupling Hypothesis of Aging, Journal of Cognitive Neuroscience, vol.27, issue.12, pp.2462-76, 2015.
DOI : 10.1016/j.neuropsychologia.2006.05.014

C. Jack, H. Wiste, S. Weigand, and T. Therneau, Age-specific and sex-specific prevalence of cerebral ??-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50???95 years: a cross-sectional study, The Lancet Neurology, vol.16, issue.6, 2017.
DOI : 10.1016/S1474-4422(17)30077-7

R. Sperling, D. Rentz, K. Johnson, J. Karlawish, M. Donohue et al., Aisen P The A4 study: stopping AD before symptoms begin? Sci Transl Med, pp.228-241, 2014.
DOI : 10.1126/scitranslmed.3007941
URL : http://europepmc.org/articles/pmc4049292?pdf=render

K. Pike, K. Ellis, and V. Villemagne, Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study, Neuropsychologia, vol.49, issue.9, pp.2384-90, 2011.
DOI : 10.1016/j.neuropsychologia.2011.04.012

M. Harrington, J. Chiang, and J. Pogoda, Executive Function Changes before Memory in Preclinical Alzheimer???s Pathology: A Prospective, Cross-Sectional, Case Control Study, PLoS ONE, vol.13, issue.11, p.79378, 2013.
DOI : 10.1371/journal.pone.0079378.t008

J. Whitwell, N. Tosakulwong, and S. Weigand, Does amyloid deposition produce a specific atrophic signature in cognitively normal subjects?, NeuroImage: Clinical, vol.2, pp.249-57, 2013.
DOI : 10.1016/j.nicl.2013.01.006

D. Knopman, C. Jack, . Jr, and H. Wiste, Brain injury biomarkers are not dependent on ??-amyloid in normal elderly, Annals of Neurology, vol.25, issue.4, pp.472-80, 2013.
DOI : 10.1097/WCO.0b013e32835a30f4

C. Jack, . Jr, H. Wiste, and S. Weigand, Age-specific population frequencies of cerebral ??-amyloidosis and neurodegeneration among people with normal cognitive function aged 50???89 years: a cross-sectional study, The Lancet Neurology, vol.13, issue.10, pp.997-1005, 2014.
DOI : 10.1016/S1474-4422(14)70194-2

J. Fortea, E. Vilaplana, and D. Alcolea, Cerebrospinal fluid ??-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease, Annals of Neurology, vol.32, issue.pt 5, pp.223-253, 2014.
DOI : 10.1523/JNEUROSCI.2170-12.2012

K. Papp, R. Amariglio, and E. Mormino, Free and cued memory in relation to biomarker-defined abnormalities in clinically normal older adults and those at risk for Alzheimer???s disease, Neuropsychologia, vol.73, pp.169-75, 2015.
DOI : 10.1016/j.neuropsychologia.2015.04.034

J. Hassenstab, R. Chasse, and P. Grabow, Certified normal: Alzheimer's disease biomarkers and normative estimates of cognitive functioning, Neurobiology of Aging, vol.43, pp.23-33, 2016.
DOI : 10.1016/j.neurobiolaging.2016.03.014

O. Voevodskaya, P. Sundgren, and O. Strandberg, genotype in Alzheimer disease, Neurology, vol.86, issue.19, pp.1754-61, 2016.
DOI : 10.1212/WNL.0000000000002672

R. Desikan, L. Mcevoy, and W. Thompson, Amyloid-?????Associated Clinical Decline Occurs Only in the Presence of Elevated P-tau, Archives of Neurology, vol.69, issue.6, pp.709-722, 2012.
DOI : 10.1001/archneurol.2011.3354

D. Knopman, C. Jack, . Jr, and H. Wiste, Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease, Neurology, vol.78, issue.20, pp.1576-82, 2012.
DOI : 10.1212/WNL.0b013e3182563bbe

S. Stark, C. Roe, and E. Grant, Preclinical Alzheimer disease and risk of falls, Neurology, vol.81, issue.5, pp.437-480, 2013.
DOI : 10.1212/WNL.0b013e31829d8599

Y. Lim, V. Villemagne, and S. Laws, BDNF Val66Met, A?? amyloid, and cognitive decline in preclinical Alzheimer's disease, Neurobiology of Aging, vol.34, issue.11, pp.2457-64, 2013.
DOI : 10.1016/j.neurobiolaging.2013.05.006

Y. Lim, P. Maruff, and R. Pietrzak, Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer???s disease, Brain, vol.51, issue.1, pp.221-252, 2014.
DOI : 10.2967/jnumed.109.069088